Picture of Pharmasimple SA logo

ALPHS Pharmasimple SA Cashflow Statement

0.000.00%
fr flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro Cap

Annual cashflow statement for Pharmasimple SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2016
December 31st
2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
Period Length:12 M12 M
Source:Interim ReportInterim Report
Standards:
BAS
BAS
Status:FinalFinal
fx
Preliminary
fx
Preliminary
fx
Preliminary
Net Income/Starting Line-0.941-1.37
Depreciation
Changes in Working Capital-0.765-1.85
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1.44-2.9
Capital Expenditures-0.481
Purchase of Fixed Assets
Other Investing Cash Flow Items0
Sale of Fixed Assets
Cash from Investing Activities-0.4810
Financing Cash Flow Items-0.077
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.935.71
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0132.81